Macy’s (M - Free Report) is one of the nation's premier retailers, operating about 885 stores in 45 states, the District of Columbia, Guam and Puerto Rico, under the names of Macy's, Bloomingdale's, Bloomingdale's Outlet and Bluemercury, as well as the macys.com, bloomingdales.com and bluemercury.com websites.
The company recently reported Q4 17 results where they beat the Zacks consensus earnings estimate for the third consecutive quarter, but came in just short of the revenue estimate. But overall, the year over year data was better than expected with sales rising by +1.8%, comparable sales improving by +1.3%, and adjusted diluted EPS (taking out deductions from the tax reform law) growing by +39.6%. Also, on a fiscal year basis, operating income jumped up by +48.8%, and net cash flows rose by +7.9%. To add to the positive quarterly results, management noted that these positive trends carried into January (Q1 18) as comps, gross margins, and merchandise margins seeing year over year strength.
As part of the company’s cost cutting plans, the company has been focused on several key components; the opening of new stores, the closures of less profitable stores, and its real estate portfolio. In 2017, they opened 36 Bluemercury stores, 2 Macy’s stores, and one Bloomingdale store. At the same time the company has closed 83 out of the 100 stores that they had earmarked in late 2016. As for its real estate portfolio, Macy’s gained $411 million in cash proceeds from sales of assets, these sales included warehouses, parking garages, and outparcels. Going into FY 2018 management remains focused on evaluating its real estate portfolio for new opportunities, and the departure of non-strategic locations.
Due to these positive data points, management guided FY 19 EPS, revenue, and comparable store sales above consensus. EPS is now expected to be between $3.55-3.75, above the previous expectation of $3.03, Revenues between $24.34-24.71 billion verses $24.34 billion, and comparable store sales to be between 0-1% well above the previous expectation of a decline of -1.3%.
This news caused analyst estimates for Q1 18, Q2 18, FY 18, and FY 19 to all see positive estimate revisions over the past 30 days; Q1 18 improved from $0.23 to $0.38, Q2 18 grew from $$0.40 to $0.53, FY 18 rose from $2.80 to $3.63, and FY 19 jumped from $1.67 to $3.17.
The big turnaround at Macy’s can be seen in the Price and Earnings Consensus Graph below.
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Macy’s (M - Free Report) is one of the nation's premier retailers, operating about 885 stores in 45 states, the District of Columbia, Guam and Puerto Rico, under the names of Macy's, Bloomingdale's, Bloomingdale's Outlet and Bluemercury, as well as the macys.com, bloomingdales.com and bluemercury.com websites.
The company recently reported Q4 17 results where they beat the Zacks consensus earnings estimate for the third consecutive quarter, but came in just short of the revenue estimate. But overall, the year over year data was better than expected with sales rising by +1.8%, comparable sales improving by +1.3%, and adjusted diluted EPS (taking out deductions from the tax reform law) growing by +39.6%. Also, on a fiscal year basis, operating income jumped up by +48.8%, and net cash flows rose by +7.9%. To add to the positive quarterly results, management noted that these positive trends carried into January (Q1 18) as comps, gross margins, and merchandise margins seeing year over year strength.
As part of the company’s cost cutting plans, the company has been focused on several key components; the opening of new stores, the closures of less profitable stores, and its real estate portfolio. In 2017, they opened 36 Bluemercury stores, 2 Macy’s stores, and one Bloomingdale store. At the same time the company has closed 83 out of the 100 stores that they had earmarked in late 2016. As for its real estate portfolio, Macy’s gained $411 million in cash proceeds from sales of assets, these sales included warehouses, parking garages, and outparcels. Going into FY 2018 management remains focused on evaluating its real estate portfolio for new opportunities, and the departure of non-strategic locations.
Due to these positive data points, management guided FY 19 EPS, revenue, and comparable store sales above consensus. EPS is now expected to be between $3.55-3.75, above the previous expectation of $3.03, Revenues between $24.34-24.71 billion verses $24.34 billion, and comparable store sales to be between 0-1% well above the previous expectation of a decline of -1.3%.
This news caused analyst estimates for Q1 18, Q2 18, FY 18, and FY 19 to all see positive estimate revisions over the past 30 days; Q1 18 improved from $0.23 to $0.38, Q2 18 grew from $$0.40 to $0.53, FY 18 rose from $2.80 to $3.63, and FY 19 jumped from $1.67 to $3.17.
The big turnaround at Macy’s can be seen in the Price and Earnings Consensus Graph below.
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on EMR - FREE
Get the latest research report on M - FREE